520 related articles for article (PubMed ID: 21791482)
21. ThyroSeq v3 for Bethesda III and IV: An institutional experience.
Desai D; Lepe M; Baloch ZW; Mandel SJ
Cancer Cytopathol; 2021 Feb; 129(2):164-170. PubMed ID: 33030808
[TBL] [Abstract][Full Text] [Related]
22. Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology.
Singh RS; Wang HH
Am J Clin Pathol; 2011 Dec; 136(6):896-902. PubMed ID: 22095375
[TBL] [Abstract][Full Text] [Related]
23. Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology.
Chen JC; Pace SC; Chen BA; Khiyami A; McHenry CR
Surgery; 2012 Dec; 152(6):1037-44. PubMed ID: 23040711
[TBL] [Abstract][Full Text] [Related]
24. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R
Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624
[TBL] [Abstract][Full Text] [Related]
25. Reclassifying formerly indeterminate thyroid FNAs using the Bethesda system reduces the number of inconclusive cases.
Song JY; Chu YC; Kim L; Park IS; Han JY; Kim JM
Acta Cytol; 2012; 56(2):122-9. PubMed ID: 22378073
[TBL] [Abstract][Full Text] [Related]
26. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
[TBL] [Abstract][Full Text] [Related]
27. What is the malignancy risk for atypia of undetermined significance? Three years' experience at a university hospital in Turkey.
Gocun PU; Karakus E; Bulutay P; Akturk M; Akin M; Poyraz A
Cancer Cytopathol; 2014 Aug; 122(8):604-10. PubMed ID: 24890894
[TBL] [Abstract][Full Text] [Related]
28. The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy.
Wu HH; Rose C; Elsheikh TM
Diagn Cytopathol; 2012 May; 40(5):399-403. PubMed ID: 21681976
[TBL] [Abstract][Full Text] [Related]
29. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
[TBL] [Abstract][Full Text] [Related]
30. Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
Higuchi M; Hirokawa M; Kanematsu R; Tanaka A; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
Endocr J; 2018 Dec; 65(12):1193-1198. PubMed ID: 30282887
[TBL] [Abstract][Full Text] [Related]
31. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.
Mehta RS; Carty SE; Ohori NP; Hodak SP; Coyne C; LeBeau SO; Tublin ME; Stang MT; Johnson JT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L
Surgery; 2013 Oct; 154(4):730-6; discussion 736-8. PubMed ID: 24074409
[TBL] [Abstract][Full Text] [Related]
32. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
Straccia P; Rossi ED; Bizzarro T; Brunelli C; Cianfrini F; Damiani D; Fadda G
Cancer Cytopathol; 2015 Dec; 123(12):713-22. PubMed ID: 26355876
[TBL] [Abstract][Full Text] [Related]
33. Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy.
Kuru B; Atmaca A; Kefeli M
Diagn Cytopathol; 2016 May; 44(5):394-8. PubMed ID: 26917413
[TBL] [Abstract][Full Text] [Related]
34. Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
Lim JXY; Nga ME; Chan DKH; Tan WB; Parameswaran R; Ngiam KY
Thyroid; 2018 Apr; 28(4):511-521. PubMed ID: 29596039
[TBL] [Abstract][Full Text] [Related]
35. Indeterminate pediatric thyroid fine needle aspirations: a study of 68 cases.
Smith M; Pantanowitz L; Khalbuss WE; Benkovich VA; Monaco SE
Acta Cytol; 2013; 57(4):341-8. PubMed ID: 23859872
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of surgeon-performed ultrasound-guided fine-needle aspiration of thyroid nodules.
Bohacek L; Milas M; Mitchell J; Siperstein A; Berber E
Ann Surg Oncol; 2012 Jan; 19(1):45-51. PubMed ID: 21633868
[TBL] [Abstract][Full Text] [Related]
37. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
38. Examining the Bethesda criteria risk stratification of thyroid nodules.
Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
[TBL] [Abstract][Full Text] [Related]
39. Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: Experience of a Tertiary Care Referral Center.
Heider A; Arnold S; Jing X
Arch Pathol Lab Med; 2020 Apr; 144(4):473-477. PubMed ID: 31403334
[TBL] [Abstract][Full Text] [Related]
40. Malignancy rate of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid nodules undergoing FNA in a suburban endocrinology practice: A retrospective cohort analysis.
Seagrove-Guffey MA; Hatic H; Peng H; Bates KC; Odugbesan AO
Cancer Cytopathol; 2018 Oct; 126(10):881-888. PubMed ID: 30335212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
